Matsubara S, Sato M, Ohye H, Murao K, Takahara J
First Department of Internal Medicine, Kagawa Medical University, Japan.
Endocrinology. 1997 Nov;138(11):5075-8. doi: 10.1210/endo.138.11.5654.
We have developed a novel method of quantifying growth hormone(GH) pre-mRNA expression in anterior pituitary cells. DNA-free total RNA extracted from cultured rat anterior pituitary cells was reverse transcribed(RT) to cDNA, and RT products were subsequently quantitated by competitive PCR using intron-specific primers of rat GH gene. After 6-h of incubation in treated cells, dexamethasone(Dex) and triiodo-L-thyronine(T3) significantly increased GH pre-mRNA levels(3.2- and 2.2-fold compared to non-treated cells, respectively). However, Northern blot analysis did not detect significant changes in GH mRNA levels. After 24-h incubation with Dex and T3, significant increases in GH mRNA levels were detected on Northern blots, but GH pre-mRNA levels did not differ between treated and non-treated cells. These findings suggest that both Dex and T3 treatments rapidly increase GH pre-mRNA levels in normal somatotropes. This method has high sensitivity and widespread application to the analysis of pre-mRNAs of target genes.
我们开发了一种新方法,用于定量前脑垂体细胞中生长激素(GH)前体mRNA的表达。从培养的大鼠前脑垂体细胞中提取无DNA的总RNA,将其逆转录(RT)为cDNA,随后使用大鼠GH基因的内含子特异性引物通过竞争性PCR对RT产物进行定量。在处理过的细胞中孵育6小时后,地塞米松(Dex)和三碘甲状腺原氨酸(T3)显著提高了GH前体mRNA水平(分别比未处理细胞高3.2倍和2.2倍)。然而,Northern印迹分析未检测到GH mRNA水平的显著变化。在用Dex和T3孵育24小时后,Northern印迹检测到GH mRNA水平显著增加,但处理过的细胞与未处理的细胞之间GH前体mRNA水平没有差异。这些发现表明,Dex和T3处理均可迅速提高正常生长激素细胞中GH前体mRNA水平。该方法具有高灵敏度,广泛应用于靶基因前体mRNA的分析。